Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for LEGN

Stock Name	Legend Biotech Corp
Ticker	LEGN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US52490G1022
LEI	254900EIUFZTW136H859

Show aggregate LEGN holdings

News associated with LEGN

Brokerages Set Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Price Target at $74.22: Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eleven ratings firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average 12 month price […] - 2025-09-19 02:43:01
Legend Biotech Becomes Oversold (LEGN): Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me - 2025-09-10 14:53:11
JPMorgan Chase & Co. Increases Legend Biotech (NASDAQ:LEGN) Price Target to $78.00: Legend Biotech (NASDAQ:LEGN – Get Free Report) had its price target raised by research analysts at JPMorgan Chase & Co. from $77.00 to $78.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of […] - 2025-08-27 02:30:45
Legend Biotech Breaks Below 200-Day Moving Average - Notable for LEGN: In trading on Monday, shares of Legend Biotech Corp (Symbol: LEGN) crossed below their 200 day moving average of $36.28, changing hands as low as $35.23 per share. Legend Biotech Corp shares are currently trading off about 2.5% on the day. The chart below shows the one year pe - 2025-08-11 12:46:01
Legend Biotech (NASDAQ:LEGN) Rating Increased to Strong-Buy at Cantor Fitzgerald: Legend Biotech (NASDAQ:LEGN – Get Free Report) was upgraded by analysts at Cantor Fitzgerald to a “strong-buy” rating in a note issued to investors on Monday,Zacks.com reports. Other equities research analysts also recently issued research reports about the company. Johnson Rice reissued a “buy” rating on shares of Legend Biotech in a research report on […] - 2025-08-06 03:12:50
GAMMA Investing LLC Boosts Position in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN): GAMMA Investing LLC increased its holdings in shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN – Free Report) by 145.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,291 shares of the company’s stock after purchasing an additional 765 […] - 2025-07-11 04:12:51
Legend Biotech (NASDAQ:LEGN) Receives Buy Rating from HC Wainwright: Legend Biotech (NASDAQ:LEGN – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They currently have a $75.00 price target on the stock. HC Wainwright’s price objective indicates a potential upside of 90.07% from the company’s previous close. A number of other […] - 2025-07-10 04:01:26
Rhumbline Advisers Purchases 391 Shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN): Rhumbline Advisers lifted its position in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN – Free Report) by 1.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 28,029 shares of the company’s stock after acquiring an additional 391 shares during the quarter. Rhumbline Advisers’ holdings […] - 2025-06-20 04:25:11
Thursday's ETF with Unusual Volume: FTQI: The First Trust Nasdaq BuyWrite Income ETF is seeing unusually high volume in afternoon trading Thursday, with over 909,000 shares traded versus three month average volume of about 226,000. Shares of FTQI were down about 0.2% on the day. Components of that ETF with the highest - 2025-06-12 15:09:39
Tuesday's ETF with Unusual Volume: EEMA: The iShares MSCI Emerging Markets Asia ETF is seeing unusually high volume in afternoon trading Tuesday, with over 2.5 million shares traded versus three month average volume of about 92,000. Shares of EEMA were up about 0.3% on the day. Components of that ETF with the highest - 2025-06-10 14:57:32
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 36,181 Shares of Legend Biotech Co. (NASDAQ:LEGN): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 36.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 136,438 shares of the company’s stock after […] - 2025-06-04 05:02:51
Nuveen Asset Management LLC Acquires 5,700 Shares of Legend Biotech Co. (NASDAQ:LEGN): Nuveen Asset Management LLC grew its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 5.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 110,586 shares of the company’s stock after purchasing an additional 5,700 shares during the period. Nuveen Asset Management LLC’s […] - 2025-06-02 05:04:55
Legend Biotech Co. (NASDAQ:LEGN) Shares Acquired by Squarepoint Ops LLC: Squarepoint Ops LLC grew its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 44.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 127,900 shares of the company’s stock after acquiring an additional 39,197 shares during the quarter. Squarepoint Ops […] - 2025-05-27 05:13:00
Millennium Management LLC Has $8.31 Million Holdings in Legend Biotech Co. (NASDAQ:LEGN): Millennium Management LLC lessened its stake in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 55.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 255,468 shares of the company’s stock after selling 314,908 shares during the quarter. Millennium Management LLC’s […] - 2025-05-26 04:42:54
Deutsche Bank AG Acquires 14,198 Shares of Legend Biotech Co. (NASDAQ:LEGN): Deutsche Bank AG lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 11.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 135,067 shares of the company’s stock after acquiring an additional 14,198 shares during the period. Deutsche Bank […] - 2025-05-20 05:12:55
Legend Biotech (NASDAQ:LEGN) Hits New 12-Month Low After Analyst Downgrade: Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) hit a new 52-week low during mid-day trading on Thursday after Truist Financial lowered their price target on the stock from $88.00 to $71.00. Truist Financial currently has a buy rating on the stock. Legend Biotech traded as low as $27.54 and last traded at […] - 2025-05-16 03:02:47
Legend Biotech Co. (NASDAQ:LEGN) Stake Boosted by Stifel Financial Corp: Stifel Financial Corp increased its position in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 70.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,365 shares of the company’s stock after acquiring an additional 12,955 shares […] - 2025-05-09 05:58:54
Zurcher Kantonalbank Zurich Cantonalbank Trims Position in Legend Biotech Co. (NASDAQ:LEGN): Zurcher Kantonalbank Zurich Cantonalbank decreased its position in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 18.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 40,913 shares of the company’s stock after selling 9,355 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Legend […] - 2025-03-19 05:40:51
Morgan Stanley Issues Pessimistic Forecast for Legend Biotech (NASDAQ:LEGN) Stock Price: Legend Biotech (NASDAQ:LEGN – Get Free Report) had its target price dropped by analysts at Morgan Stanley from $82.00 to $80.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s target price points to a potential upside of 111.19% from the company’s current […] - 2025-03-19 04:28:56
Daiwa Securities Group Inc. Raises Stock Position in Legend Biotech Co. (NASDAQ:LEGN): Daiwa Securities Group Inc. lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 165.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 8,516 shares of the company’s stock after acquiring an additional 5,309 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Legend Biotech were worth $278,000 as […] - 2025-03-17 06:06:55
Company News for Mar 12, 2025: Companies in The News Are: FRG, ORCL, LEGN, PAY - 2025-03-12 11:20:00
Legend Biotech Co. (NASDAQ:LEGN) Receives $79.50 Average PT from Brokerages: Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) have been given a consensus rating of “Buy” by the twelve research firms that are covering the stock, MarketBeat Ratings reports. Twelve analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the stock […] - 2025-03-03 04:50:55
Legend Biotech Co. (NASDAQ:LEGN) Shares Sold by Sumitomo Mitsui Trust Group Inc.: Sumitomo Mitsui Trust Group Inc. lowered its stake in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 2.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 173,766 shares of the company’s stock after selling 3,461 shares during the quarter. Sumitomo Mitsui Trust […] - 2025-02-14 07:35:09
Contrasting Legend Biotech (NASDAQ:LEGN) and COMPASS Pathways (NASDAQ:CMPS): COMPASS Pathways (NASDAQ:CMPS – Get Free Report) and Legend Biotech (NASDAQ:LEGN – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Earnings & Valuation This table compares COMPASS Pathways […] - 2025-02-06 04:06:58
How The Parts Add Up: KOMP Headed For $62: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-02-04 10:28:33

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) LEGN holdings

Date	Number of LEGN Shares Held	Base Market Value of LEGN Shares	Local Market Value of LEGN Shares	Change in LEGN Shares Held	Change in LEGN Base Value	Current Price per LEGN Share Held	Previous Price per LEGN Share Held
2025-11-11 (Tuesday)	54,510	USD 1,745,955	USD 1,745,955	0	USD 23,984	USD 32.03	USD 31.59
2025-11-10 (Monday)	54,510	USD 1,721,971	USD 1,721,971	139	USD -7,027	USD 31.59	USD 31.8
2025-11-07 (Friday)	54,371	USD 1,728,998	USD 1,728,998	0	USD -30,991	USD 31.8	USD 32.37
2025-11-06 (Thursday)	54,371	USD 1,759,989	USD 1,759,989	139	USD 24,023	USD 32.37	USD 32.01
2025-11-05 (Wednesday)	54,232	USD 1,735,966	USD 1,735,966	0	USD -2,170	USD 32.01	USD 32.05
2025-11-04 (Tuesday)	54,232	USD 1,738,136	USD 1,738,136	140	USD 160	USD 32.05	USD 32.13
2025-11-03 (Monday)	54,092	USD 1,737,976	USD 1,737,976	0	USD -14,605	USD 32.13	USD 32.4
2025-10-31 (Friday)	54,092	USD 1,752,581	USD 1,752,581	0	USD 8,114	USD 32.4	USD 32.25
2025-10-30 (Thursday)	54,092	USD 1,744,467	USD 1,744,467	700	USD 28,982	USD 32.25	USD 32.13
2025-10-29 (Wednesday)	53,392	USD 1,715,485	USD 1,715,485	280	USD -14,373	USD 32.13	USD 32.57
2025-10-28 (Tuesday)	53,112	USD 1,729,858	USD 1,729,858	0	USD 23,901	USD 32.57	USD 32.12
2025-10-27 (Monday)	53,112	USD 1,705,957	USD 1,705,957	0	USD 13,809	USD 32.12	USD 31.86

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LEGN by Blackrock for IE00BYXG2H39

Show aggregate share trades of LEGN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 139 32.300 31.360 31.454 USD 4,372 36.02
2025-11-06 BUY 139 32.555 31.310 31.434 USD 4,369 36.06
2025-11-04 BUY 140 32.800 31.580 31.702 USD 4,438 36.10
2025-10-30 BUY 700 32.600 31.600 31.700 USD 22,190 36.16
2025-10-29 BUY 280 32.130 32.710 32.652 USD 9,143 36.19
2025-10-22 SELL -560 32.110 32.900 32.821 USD -18,380 36.30 Profit of 1,946 on sale
2025-10-20 BUY 280 32.910 33.070 33.054 USD 9,255 36.33
2025-10-17 BUY 699 31.960 32.270 32.239 USD 22,535 36.36
2025-10-15 BUY 1,112 33.720 34.800 34.692 USD 38,578 36.37
2025-10-03 BUY 980 32.060 32.340 32.312 USD 31,666 36.41
2025-10-02 BUY 140 32.290 33.235 33.141 USD 4,640 36.44
2025-09-30 BUY 280 32.610 33.540 33.447 USD 9,365 36.48
2025-09-26 BUY 280 33.370 33.460 33.451 USD 9,366 36.52
2025-09-25 BUY 280 32.820 32.875 32.869 USD 9,203 36.54
2025-09-24 BUY 1 32.880 33.311 33.268 USD 33 36.56
2025-09-18 BUY 140 35.160 35.400 35.376 USD 4,953 36.57
2025-09-17 BUY 420 34.470 35.150 35.082 USD 14,734 36.58
2025-08-20 SELL -560 35.630 36.700 36.593 USD -20,492 36.62 Profit of 15 on sale
2025-07-30 BUY 560 40.410 41.605 41.485 USD 23,232 36.57
2025-07-17 SELL -280 42.130 42.670 42.616 USD -11,932 36.21 Loss of -1,795 on sale
2025-07-11 SELL -1,120 38.960 39.506 39.451 USD -44,186 36.12 Loss of -3,734 on sale
2025-07-07 BUY 420 35.870 36.005 35.992 USD 15,116 36.06
2025-07-02 BUY 7,700 35.910 36.770 36.684 USD 282,467 36.06
2025-06-20 BUY 1,142 34.000 34.890 34.801 USD 39,743 36.08
2025-06-11 BUY 272 36.590 37.900 37.769 USD 10,273 36.09
2025-06-10 BUY 272 37.640 38.000 37.964 USD 10,326 36.07
2025-06-04 SELL -136 30.360 32.445 32.236 USD -4,384 36.17 Profit of 535 on sale
2025-04-23 BUY 136 34.300 35.319 35.217 USD 4,790 37.78
2025-04-10 SELL -1,088 31.280 32.830 32.675 USD -35,550 38.29 Profit of 6,104 on sale
2025-04-08 SELL -136 30.770 31.660 31.571 USD -4,294 38.44 Profit of 935 on sale
2025-04-07 SELL -136 30.250 31.700 31.555 USD -4,291 38.54 Profit of 950 on sale
2025-04-04 SELL -680 32.010 32.370 32.334 USD -21,987 38.62 Profit of 4,271 on sale
2025-04-01 BUY 1,230 31.520 34.840 34.508 USD 42,445 38.77
2025-03-31 SELL -402 33.930 34.410 34.362 USD -13,814 38.82 Profit of 1,794 on sale
2025-03-21 BUY 1,747 36.950 37.370 37.328 USD 65,212 39.08
2025-03-14 SELL -2,048 37.200 38.705 38.555 USD -78,960 39.17 Profit of 1,268 on sale
2025-03-07 SELL -256 35.260 35.445 35.426 USD -9,069 39.37 Profit of 1,010 on sale
2025-03-04 SELL -128 33.980 34.300 34.268 USD -4,386 39.61 Profit of 684 on sale
2025-02-25 BUY 256 37.010 38.500 38.351 USD 9,818 39.96
2025-02-19 SELL -128 38.750 39.235 39.187 USD -5,016 40.06 Profit of 111 on sale
2025-02-13 BUY 384 36.390 37.110 37.038 USD 14,223 40.31
2025-02-12 BUY 128 35.870 35.970 35.960 USD 4,603 40.40
2025-02-11 BUY 512 34.630 35.610 35.512 USD 18,182 40.52
2024-12-30 SELL -4,533 32.770 32.913 32.899 USD -149,130 42.39 Profit of 43,021 on sale
2024-11-18 SELL -2,100 37.420 39.690 39.463 USD -82,872 43.53 Profit of 8,533 on sale
2024-11-08 SELL -140 40.030 40.840 40.759 USD -5,706 44.02 Profit of 456 on sale
2024-10-21 SELL -140 43.450 44.480 44.377 USD -6,213 0.00 Loss of -6,213 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	139	32.300	31.360	31.454	USD 4,372	36.02
2025-11-06	BUY	139	32.555	31.310	31.434	USD 4,369	36.06
2025-11-04	BUY	140	32.800	31.580	31.702	USD 4,438	36.10
2025-10-30	BUY	700	32.600	31.600	31.700	USD 22,190	36.16
2025-10-29	BUY	280	32.130	32.710	32.652	USD 9,143	36.19
2025-10-22	SELL	-560	32.110	32.900	32.821	USD -18,380	36.30 Profit of 1,946 on sale
2025-10-20	BUY	280	32.910	33.070	33.054	USD 9,255	36.33
2025-10-17	BUY	699	31.960	32.270	32.239	USD 22,535	36.36
2025-10-15	BUY	1,112	33.720	34.800	34.692	USD 38,578	36.37
2025-10-03	BUY	980	32.060	32.340	32.312	USD 31,666	36.41
2025-10-02	BUY	140	32.290	33.235	33.141	USD 4,640	36.44
2025-09-30	BUY	280	32.610	33.540	33.447	USD 9,365	36.48
2025-09-26	BUY	280	33.370	33.460	33.451	USD 9,366	36.52
2025-09-25	BUY	280	32.820	32.875	32.869	USD 9,203	36.54
2025-09-24	BUY	1	32.880	33.311	33.268	USD 33	36.56
2025-09-18	BUY	140	35.160	35.400	35.376	USD 4,953	36.57
2025-09-17	BUY	420	34.470	35.150	35.082	USD 14,734	36.58
2025-08-20	SELL	-560	35.630	36.700	36.593	USD -20,492	36.62 Profit of 15 on sale
2025-07-30	BUY	560	40.410	41.605	41.485	USD 23,232	36.57
2025-07-17	SELL	-280	42.130	42.670	42.616	USD -11,932	36.21 Loss of -1,795 on sale
2025-07-11	SELL	-1,120	38.960	39.506	39.451	USD -44,186	36.12 Loss of -3,734 on sale
2025-07-07	BUY	420	35.870	36.005	35.992	USD 15,116	36.06
2025-07-02	BUY	7,700	35.910	36.770	36.684	USD 282,467	36.06
2025-06-20	BUY	1,142	34.000	34.890	34.801	USD 39,743	36.08
2025-06-11	BUY	272	36.590	37.900	37.769	USD 10,273	36.09
2025-06-10	BUY	272	37.640	38.000	37.964	USD 10,326	36.07
2025-06-04	SELL	-136	30.360	32.445	32.236	USD -4,384	36.17 Profit of 535 on sale
2025-04-23	BUY	136	34.300	35.319	35.217	USD 4,790	37.78
2025-04-10	SELL	-1,088	31.280	32.830	32.675	USD -35,550	38.29 Profit of 6,104 on sale
2025-04-08	SELL	-136	30.770	31.660	31.571	USD -4,294	38.44 Profit of 935 on sale
2025-04-07	SELL	-136	30.250	31.700	31.555	USD -4,291	38.54 Profit of 950 on sale
2025-04-04	SELL	-680	32.010	32.370	32.334	USD -21,987	38.62 Profit of 4,271 on sale
2025-04-01	BUY	1,230	31.520	34.840	34.508	USD 42,445	38.77
2025-03-31	SELL	-402	33.930	34.410	34.362	USD -13,814	38.82 Profit of 1,794 on sale
2025-03-21	BUY	1,747	36.950	37.370	37.328	USD 65,212	39.08
2025-03-14	SELL	-2,048	37.200	38.705	38.555	USD -78,960	39.17 Profit of 1,268 on sale
2025-03-07	SELL	-256	35.260	35.445	35.426	USD -9,069	39.37 Profit of 1,010 on sale
2025-03-04	SELL	-128	33.980	34.300	34.268	USD -4,386	39.61 Profit of 684 on sale
2025-02-25	BUY	256	37.010	38.500	38.351	USD 9,818	39.96
2025-02-19	SELL	-128	38.750	39.235	39.187	USD -5,016	40.06 Profit of 111 on sale
2025-02-13	BUY	384	36.390	37.110	37.038	USD 14,223	40.31
2025-02-12	BUY	128	35.870	35.970	35.960	USD 4,603	40.40
2025-02-11	BUY	512	34.630	35.610	35.512	USD 18,182	40.52
2024-12-30	SELL	-4,533	32.770	32.913	32.899	USD -149,130	42.39 Profit of 43,021 on sale
2024-11-18	SELL	-2,100	37.420	39.690	39.463	USD -82,872	43.53 Profit of 8,533 on sale
2024-11-08	SELL	-140	40.030	40.840	40.759	USD -5,706	44.02 Profit of 456 on sale
2024-10-21	SELL	-140	43.450	44.480	44.377	USD -6,213	0.00 Loss of -6,213 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LEGN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	298,552	313	560,267	53.3%
2025-09-18	438,030	0	811,810	54.0%
2025-09-17	326,421	0	604,296	54.0%
2025-09-16	311,042	401	615,952	50.5%
2025-09-15	260,973	622	447,862	58.3%
2025-09-12	426,469	700	897,990	47.5%
2025-09-11	693,338	0	855,833	81.0%
2025-09-10	888,564	0	1,313,429	67.7%
2025-09-09	340,405	0	706,284	48.2%
2025-09-08	217,484	0	481,969	45.1%
2025-09-05	494,736	0	832,555	59.4%
2025-09-04	184,038	0	343,134	53.6%
2025-09-03	269,787	0	497,655	54.2%
2025-09-02	107,784	0	208,504	51.7%
2025-08-29	352,560	0	434,689	81.1%
2025-08-28	150,976	0	247,242	61.1%
2025-08-27	238,494	0	431,590	55.3%
2025-08-26	254,615	0	364,721	69.8%
2025-08-25	211,650	0	359,268	58.9%
2025-08-22	179,196	0	268,633	66.7%
2025-08-21	247,450	0	388,074	63.8%
2025-08-20	309,483	0	452,618	68.4%
2025-08-19	205,421	0	287,269	71.5%
2025-08-18	216,671	0	285,122	76.0%
2025-08-15	291,585	0	472,785	61.7%
2025-08-14	364,889	0	500,563	72.9%
2025-08-13	393,947	1,421	557,980	70.6%
2025-08-12	294,473	0	535,569	55.0%
2025-08-11	211,102	2,089	693,897	30.4%
2025-08-08	161,695	0	501,449	32.2%
2025-08-07	178,498	0	390,087	45.8%
2025-08-06	120,604	783	441,008	27.3%
2025-08-05	109,867	0	234,848	46.8%
2025-08-04	128,562	1,313	300,072	42.8%
2025-08-01	161,942	0	534,931	30.3%
2025-07-31	300,349	1,679	523,299	57.4%
2025-07-30	248,991	0	668,473	37.2%
2025-07-29	148,846	0	593,885	25.1%
2025-07-28	169,804	13	460,464	36.9%
2025-07-25	141,564	462	607,486	23.3%
2025-07-24	226,073	90	389,609	58.0%
2025-07-23	387,097	78	614,678	63.0%
2025-07-22	276,984	209	600,772	46.1%
2025-07-21	247,045	0	370,661	66.6%
2025-07-18	453,846	474	647,207	70.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE